**Viral News Snippet: “Trumprx”**

Viral News Snippet: “Trumprx”

URGENT: TRUMP LAUNCHES PHARMA DISRUPTER — “TRUMPRX” THREATENS BIG PHARMA BOTTOM LINE, STOCK TANKS

In a move that just shattered healthcare markets, Donald Trump unveiled Trumprx today — a direct-to-consumer pharmaceutical platform promising American-made generics at cost-plus pricing. Markets reacted instantly: major Pharma ETFs dropped 4.5% in pre-market trading, and CVS shares plunged 7%.

The model is brutal: bypass insurers, cut out PBMs, and deliver 90-day supplies for $11 flat. Trump claims the platform will undercut current prices by 60–80% on high-volume drugs like metformin, atorvastatin, and insulin analogs.

“Trumprx isn’t a campaign slogan. It’s a profit cap,” Trump said. “If you’re a CEO in this room, your margins just got a haircut.”

Analysts are scrambling. “If this scales, it’s an existential threat to pharmacy benefit managers,” notes Goldman Sachs. “The entire middleman layer could collapse within 24 months.”

The play is pure Trump: brand as weapon, supply chain as battleground. CEOs — this isn’t political noise. It’s a margin reset. Watch your Q3 forecasts.